Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

Autor: O'Byrne, Paul M, Metev, Hristo, Puu, Margareta, Richter, Kai, Keen, Christina, Uddin, Mohib, Larsson, Bengt, Cullberg, Marie, Nair, Parameswaran
Zdroj: In The Lancet Respiratory Medicine October 2016 4(10):797-806
Databáze: ScienceDirect